... model of lupus- prone mice fed high-fat chow or administered leptin had accelerated and increased proteinuria, suggesting an interplay between diet and lupus [68] Certainly, some murine lupus models ... Raggi P, Stein CM: Adipocytokines insystemiclupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis Lupus 2009, 18:799-806 53 Clancy R, Ginzler E: Endothelial ... activates plaqueresiding CD4+ T cells to increase TNF-related apoptosisinducing ligand (TRAIL) expression, which results in killing of plaque stabilizing cells and a potential increase in the risk of...
... protein autoantibody; CRP, C-reactive protein; mSLEDAI, modified systemiclupuserythematosusdisease activity index; n.s., not significant; SLEDAI, systemiclupuserythematosusdisease activity index ... during infection, systemic inflammation or tissue damage [4] The family includes long pentraxins, such as pentraxin produced by mononuclear cells in response to lipopolysaccharide, interleukin-1β ... Zoma A: The development and initial validation of the SystemicLupus International Collaborating Clinics/American College of Rheumatology damage index for systemiclupuserythematosus Arthritis Rheum...
... 20:829-833 Ginsburg WW, Finkelman FD, Lipsky PE: Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells insystemiclupuserythematosus Clin Exp Immunol 1979, 35:76-88 Klinman DM, ... and in writing the final version of the manuscript DMH assisted in the design in the study, in the interpretation of the results, and in writing the final version of the manuscript DN assisted in ... saturated in vivo with circulating BLyS, rendering them incapable of binding to BLyS in the in vitro detection assay We not yet know whether the antiBLyS autoantibodies are functionally neutralizing...
... chemokine score was dramatically increased LN, lupus nephritis; SDI, SystemicLupus International Collaborating Clinics/American Society of Rheumatology Damage Index; SLE, systemiclupuserythematosus ... chemokine ligand; CXCL, C-X-C chemokine ligand; IFIG, IFN-inducible gene; IFIT, interferon-induced protein with tetratricopeptide repeats; IL, interleukin; IP-10, interferon-inducible protein 10; ... donation using the SLE Disease Activity Index 2000 (SLEDAI-2K) [16] and the SystemicLupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) [17] Sample handling...
... vitamin K-dependent protein that has 46 to 48% amino acid identity to protein S, was discovered in the early 1990 s [15] It contains an N-terminal g-carboxyglutamic acid (Gla) domain, interacting ... of systemiclupus erythematosus; APS, antiphospholipid syndrome; BILAG, British Isles Lupus Assessment Group; F, female; M, male; SLEDAI, SystemicLupusErythematosusDisease Activity Index intra-assay ... to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemiclupuserythematosus and thrombotic and thrombocytopenic complications Clin Chem 2001, 47:1008-1015...
... the inflammatory process insystemiclupuserythematosus (SLE) and rheumatoid arthritis (RA) even though both Gas6 and sAxl in most of the patients were within the normal range [13] Systemiclupus ... that sMer is increased in active SLE and to a lesser extent in RA In contrast, neither sMer nor Tyro3 plasma concentrations are increased in CLI suggesting that the increased sMer in SLE is not ... J, Pascual V: Type I interferon insystemiclupuserythematosus and other autoimmune diseases Immunity 2006, 25:383-392 37 Pascual V, Farkas L, Banchereau J: Systemiclupus erythematosus: all roads...
... from a patient with systemiclupuserythematosus (a) Anti-FDC (follicular dendritic cell) staining within the area known as germinal centre (GC) A (b) Staining for CD20 FDC staining suggests two ... systemiclupuserythematosus Int Arch Allergy Immunol 2000, 123:36-45 27 de Wildt RMT, Tomlinson IM, van Venrooij WJ, Winter Ga, Hoet RMA: Comparable heavy and light chain pairings in normal and systemic ... complexes containing alkaline phosphatase/anti-alkaline phosphatase were detected by incubation with new fuschin substrate, and the sections were counter-stained with Mayer’s haematoxylin (Sigma)...
... Takeda T, Inoue T: Serum levels of interferons in patients with systemiclupuserythematosus Clin Exp Immunol 1987, 70:562-569 Hooks JJ, Moutsopoulos HM, Notkins AL: Circulating interferon in human ... Guanylate binding protein (GBP1) Hs00266717_m1 Guanylate binding protein (GBP2) Hs00269759_m1 IL8RA Hs00174146_m1 C-type lectin domain family 4, member E (CLEC4E) Hs00372017_m1 TNF-induced protein (TNFAIP6) ... alpha-inducible protein (IFI6) Hs00242571_m1 Interferon, gamma-inducible protein 16 (IFI16) Hs00194261_m1 Interferon, alpha-inducible protein 27 (IFI27) Hs00271467_m1 Interferon, gamma-inducible protein 30...
... The Mexican SystemicLupusErythematosusDisease Activity Index and the SystemicLupus International Collaborating Clinics/American Collage of Rheumatology Damage Indexes at the beginning of the ... ErythematosusDisease Activity Index; SLICC, SystemicLupus International Collaborating Clinics aInformation for treatment was available in 19 patients in this group bAzathioprine, methotrexate, ... active viral infection in 20 systemiclupuserythematosus patients Lupus 2000, 9:120-126 Su BY, Su CY, Yu SF, Chen CJ: Incidental discovery of high systemiclupuserythematosusdisease activity...
... ameliorate diseasein murine models of SLE In a small clinical trial, 21 daily doses of intravenous monoclonal murine anti-IL-10 antibody led to a clinical improvement in patients with SLE This was maintained ... antibodies insystemiclupuserythematosus J Rheumatol 1991, 18:230234 Lawman S, Ehrenstein MR: Many paths lead to lupusLupus 2002, 11:801-806 Ehrenstein MR, Cook HT, Neuberger MS: Deficiency in serum ... Isenberg DA: The effect of interleukin-10 and interleukin-12 on the in- vitro production of antidouble-stranded DNA antibodies from patients with systemiclupuserythematosus Clin Exp Immunol 2001,...
... Kong TQ, Kellum RE, Haserick JR: Clinical diagnosis of cardiac involvement insystemiclupus erythematosus: a correlation of clinical and autopsy findings in thirty patients Circulation 1962, ... cardiovascular risk factors insystemiclupuserythematosus J Musculoskel Med 1998, 15: 42-52 El-Magadmi M, Ahmad Y, Wajed J, Bruce IN: The bimodal mortality pattern insystemiclupuserythematosus Curr ... factors of carotid plaque in women with systemiclupuserythematosus Arthritis Rheum 1999, 42:51-60 Salmon JE, Roman MJ: Accelerated atherosclerosis insystemiclupus erythematosus: implications...
... OD All Available online http://arthritis-research.com/content/6/4/R366 Table Demographic and clinical findings in patients with systemiclupuserythematosus grouped according to their psychiatric ... protein antibodies with CNS disease, excluding lupus psychosis [51] Interestingly, the ribosomal P protein P0 has been identified by molecular cloning strategy as an endothelial autoantigen in ... Richardson EP: The neurological manifestations of systemiclupuserythematosus Medicine 1968, 47:337-369 Wekking EM: Psychiatric symptoms insystemiclupus erythematosus: an update Psychosom Med 1993,...
... [19], and by the binding of FITCconjugated Annexin V, using the Apoptest binding kit, containing annexin V-FITC and binding buffer After washing three times with PBS, cells were incubated for hour ... then incubated for 30 at 25°C in the blocking buffer (2% bovine serum albumin in PBS, containing 5% glycerol and 0.2% Tween-20) Apoptosis was evaluated by propidium iodide staining, according ... staining was observed in cells treated with TNF-α plus cycloheximide (ii) These findings were confirmed in permeabilized cells Indeed, untreated control cells showed anti-Nedd5 staining confined...
... et al.: The reliability of the SystemicLupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemiclupuserythematosus Arthritis Rheum 1997, ... Clinical Research Facility Patients underwent a full clinical assessment, including measurement of disease activity using the SLE Disease Activity Index (SLEDAI) [12] Therapy was recorded, including ... transforming growth factor-beta Lupus 1999, 8:95-102 Bruce IN, Gladman DD, Urowitz MB: Premature atherosclerosis insystemiclupuserythematosus Rheum Dis Clin North Am 2000, 26:257-278 Grainger...
... not be acceptable for use in SLE Another curious finding in the lymphoma experience is that combining epratuzumab with rituximab, although not increasing the overall clinical response rate above ... is only limited preclinical information available on the signaling mediated by epratuzumab binding to CD22 on various subsets of B cells [9] Several monoclonal antibodies against mouse CD22 have ... experience Competing interests RE has received support from Genentech for investigator and industry sponsored clinical trials, basic laboratory work and consultations regarding the development...
... with the recombinant RPA32 protein Antibodies against RPA32 were found in 10.9% (87 of 801) in breast cancer patients and in 10.3% (4 of 39) in intraductal in situ carcinoma patients, in contrast ... replication proteinA in some patients with systemiclupuserythematosus (SLE) Clin Exp Immunol 1996, 103:74-76 McNeilage LJ, Umapathysivam K, Macmillan E, Guidolin A, Whittingham S, Gordon T: Definition ... production in pristane-induced lupus J Immunol 2000, 165:1036-1043 Rubin RL: Enzyme-linked immunosorbent assay for anti-DNA and antihistone antibodies including anti-(H2A-H2B) In Manual of Clinical...
... lesions in the vicinity of sunburn cells (SBCs) in patients with systemiclupuserythematosus (SLE) Haepatients with systemiclupuserythematosus (SLE) matoxylin eosin (H&E)-stained paraffin sections ... staining), 10 mM citrate pH 6.0 (CD68 staining), or 10 mM Tris, mM EDTA pH 9.0 (CD3 staining) After washing in PBS, endogenous peroxidase was blocked by incubation in 0.37% H202 in PBS for 30 minutes ... specifically induces inflammation in LE lesions Binding of autoantibodies to apoptotic keratinocytes in the skin and subsequent pro-inflammatory clearance by macrophages could be involved in induction...
... effectively induced apoptosis in FLS even in the presence of a dominant-negative p53 Discussion Several therapeutic approaches to RA have focused on inducing apoptosis in the synovium, especially the intimal ... accumulation of cells in the lining can be due to ingress of cells from the blood, local proliferation, or insufficient deletion through apoptosis The latter is especially intriguing in view of the ... are either defective or minimally expressed in RA, including p53, sentrin [19], and PTEN (phosphatase and tensin homologue deleted on chromosome 10 [20] p53 is an interesting potential therapeutic...